Articles about 'Ravindra Gupta'

Cambridge start-up SMi and its research partners have received two Innovate UK awards to progress their work on testing for infectious diseases and detecting biomarkers for cancer.

Scientists have released the first real-world data from Africa on the effectiveness of two doses of AstraZeneca/ChaAd0x-1 COVID-19 vaccination, showing that while protective against SARS-CoV-2, immunity against the Delta and Omicron variants was lower, even in the context of prior infection or infection after vaccination.

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge – but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs.

Three Cambridge researchers are among six leading UK scientists who will share the presenting duties with Professor Jonathan Van-Tam during this year’s Christmas Lectures from the Royal Institution.

The severe outbreak of COVID-19 in Delhi, India, in 2021 showed not only that the Delta variant of SARS-CoV2 is extremely transmissible but that it can infect individuals previously infected by a different variant of the coronavirus, say a team of international scientists writing in Science.

Findings suggest infection control measures against variants will need to continue in the post-vaccination era. 

An established virologist specialising in the field of HIV drug-resistance, Ravi Gupta pivoted his expertise to address the COVID-19 pandemic. Over the last 18 months his pioneering research has helped us to stay one step ahead of emerging variants. He talks about his career as an infectious disease specialist and, in celebration of South Asian Heritage Month, what his heritage means to him.

One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome cracks in its armour as it evolves, say an international team of scientists.

Cambridge scientists are among the new Fellows announced today by the Academy of Medical Sciences.

Professor Sharon Peacock explains the story behind the UK's world-leading SARS-CoV-2 genomics capability.